Supriya Lifescience Limited announced appointment of Mr. Krishna Raghunathan as the Chief Financial Officer (KMP) of the Company with effect from January 23, 2023. Mr. Krishna Raghunathan is a dynamic professional with 23+ years of rich experience in financial management. In his last role, Mr. Raghunathan worked for ~5 years as Vice President - Finance, Treasury and Investor Relations with a listed pharmaceuticals Company.

Mr. Raghunathan has a demonstrated history of working in diverse industries including pharmaceuticals, packaging and information technology. Mr. Raghunathan is a seasoned pharma specialist with more than 2 decades of experience in companies like Dr. Reddy's Laboratories Limited and Granules India Limited. His appointment is in line with company's strategy to achieve accelerated growth in the years to come and also Mr. Ashish Nayak has resigned from the position of Chief Financial Officer & KMP of the Company and the Board has accepted his resignation with effect from close of business hours on January 23, 2023, however he will be relieved from the company on January 31, 2023, for smooth transition to his successor.